However, in immunocompetent mice, PARP7 loss significantly reduces tumor growth, particularly in mutant Parp7 H532A mice, by enhancing IFN-I signaling and CD8-positive T cell infiltration (Rasmussen et al., 2023). The gene discussed is TIPARP; the disease is neoplasm.